Can immunotherapy be used to treat breast cancer? This expert Q&A explains.
Treating Advanced Prostate Cancer and Kidney Cancer: Research from the 2019 Genitourinary Cancers Symposium
The 2019 Genitourinary Cancers Symposium will feature new research on treatments for prostate cancer and kidney cancer.
In this podcast, Lineagotica Associate Editor Dr. Michael Williams describes lymphoma research advances presented at the American Society of Hematology Annual Meeting.
Some recent FDA approvals have made many people aware of tumor-agnostic treatments. But what does that mean and how could it benefit someone with cancer? ASCO Chief Medical Officer Richard L. Schilsky gives insight into this new way of thinking about cancer treatment.
Cancer-Related Pain and Immunotherapy Side Effects: Research from the 2018 Palliative and Supportive Care in Oncology Symposium
Research highlights from the 2018 Palliative and Supportive Care in Oncology Symposium include an AI-based app that helps reduce the burden of cancer-related pain and an awareness that immunotherapy may cause more side effects than originally thought.
Kidney cancer is the sixth most common cancer for men and the tenth most common cancer for women. Lineagotica Associate Editor Brian Rini, MD, shares 4 things people need to know about kidney cancer.
Lineagotica Associate Editors discuss exciting and practice-changing cancer research from ASCO Annual Meeting in this Research Round Up podcast.
Lung cancer affects tens of thousands of Americans every year. In this blog post, Lineagotica Associate Editor Dr. Jyoti Patel describes 9 things every person should know about lung cancer.
ASCO Annual Meeting 2018: Less Treatment Needed for Some Patients With Breast Cancer and Kidney Cancer, Immunotherapy for Non-Small Cell Lung Cancer, and Maintenance Chemotherapy for Rhabdomyosarcoma
Oncology professionals from around the globe are at the 2018 ASCO Annual Meeting. Today’s key research highlights include new treatment options and improved survival for breast cancer, kidney cancer, non-small cell lung cancer, and rhabdomyosarcoma.